Condition
Cancer Gi
Total Trials
5
Recruiting
2
Active
2
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (4)
Trial Status
Recruiting2
Completed2
Not Yet Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07063706Not ApplicableCompleted
Pharmaceutical Care for Patients Using Capecitabine
NCT06964438Not ApplicableNot Yet Recruiting
Postoperative Electrical Muscle Stimulation Two
NCT05994521Not ApplicableRecruitingPrimary
Prophylactic EUS-guided Gastroenterostomy in Advanced Periampullary Cancers
NCT06581718Not ApplicableRecruitingPrimary
Eye Gaze Technology for Endoscopic Inspection of the Gastrointestinal Tract
NCT04891146Completed
The Effect of Anesthesia on Systemic Inflammatory Immune Index in Major Abdominal Cancer Surgeries
Showing all 5 trials